AU3344099A - Analgetic agent - Google Patents

Analgetic agent

Info

Publication number
AU3344099A
AU3344099A AU33440/99A AU3344099A AU3344099A AU 3344099 A AU3344099 A AU 3344099A AU 33440/99 A AU33440/99 A AU 33440/99A AU 3344099 A AU3344099 A AU 3344099A AU 3344099 A AU3344099 A AU 3344099A
Authority
AU
Australia
Prior art keywords
analgetic agent
analgetic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33440/99A
Inventor
Nobuo Kosaka
Yuko Okamura
Junichi Shimada
Tomomi Shirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of AU3344099A publication Critical patent/AU3344099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
AU33440/99A 1998-04-17 1999-04-14 Analgetic agent Abandoned AU3344099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/107681 1998-04-17
JP10768198 1998-04-17
PCT/JP1999/001982 WO1999053924A1 (en) 1998-04-17 1999-04-14 Analgetic agent

Publications (1)

Publication Number Publication Date
AU3344099A true AU3344099A (en) 1999-11-08

Family

ID=14465284

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33440/99A Abandoned AU3344099A (en) 1998-04-17 1999-04-14 Analgetic agent

Country Status (2)

Country Link
AU (1) AU3344099A (en)
WO (1) WO1999053924A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358954B1 (en) * 1999-11-09 2002-03-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
WO2003045313A2 (en) 2001-11-27 2003-06-05 Merck & Co. Inc. 2-aminoquinoline compounds
JP5992133B2 (en) * 2004-10-01 2016-09-14 メルク パテント ゲーエムベーハー Electronic devices including organic semiconductors
EP1862468A1 (en) 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one
EP1903038A1 (en) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators
DE102009034368A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-acyloxyalkylenephenyl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034367A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-benzylidene derivatives, process for their preparation and their use for the treatment of diseases
DE102009034366A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-methyleneoxyalkylene aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034362A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034526A1 (en) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-ethynylphenyl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034525A1 (en) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102010007722A1 (en) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesterone receptor antagonist
DE102010007719A1 (en) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesterone receptor antagonist
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
AU2018342089A1 (en) * 2017-09-26 2020-02-27 Dana-Farber Cancer Institute, Inc. Novel USP7 inhibitors for treating multiple myeloma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0638567A4 (en) * 1993-02-18 1995-05-10 Kyowa Hakko Kogyo Kk Adenosine incorporation inhibitor.
JPH09165385A (en) * 1994-08-26 1997-06-24 Kyowa Hakko Kogyo Co Ltd Quinazoline derivative
JPH09216883A (en) * 1996-02-09 1997-08-19 Fujisawa Pharmaceut Co Ltd Pyrazolopyridine compound and medicine containing the same compound
WO1998033792A1 (en) * 1997-01-31 1998-08-06 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives

Also Published As

Publication number Publication date
WO1999053924A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
AU4423499A (en) Novel analgesic agents
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU5970699A (en) Use
AU3344099A (en) Analgetic agent
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU1554301A (en) Radioprotecting agent
AU2656799A (en) Metal-thiols as imminomodulating agents
AUPP584198A0 (en) New use
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU8363398A (en) Capotasto
AU5757799A (en) Weed-controlling agents
AU5998199A (en) New bis-benzimidazoles
AU2609599A (en) Sensor-coupling
AU2069199A (en) Codelets
AU3204999A (en) Futureball
AU6235799A (en) New use
AU1055399A (en) Rollerboard
AU9347498A (en) Imidazotriazolopyrimidines
AU5223199A (en) Bathtub-bathseat
AU3347599A (en) Aeromobile
AU3194197A (en) Stainblocking agent
AU2840799A (en) 1-phosphanorbornadienes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase